Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Bayer’s regorafenib gains orphan status for GIST

February 4, 2011 Research and Development, Sales and Marketing Bayer, FDA, GIST, gastrointestinal stromal tumours, orphan drug, regorafenib

Bayer’s investigational compound regorafenib has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumours (GIST) …
News
Pfizer research Sandwich, Kent

ABPI backs UK science after Pfizer’s R&D exit

February 4, 2011 Research and Development Kent, Pfizer, Sandwich

The ABPI has defended the UK’s research environment against mounting criticism following Pfizer’s decision to close its Kent research base. …
News

Working Life: Merck Sharp & Dohme medical director Paul Robinson

February 4, 2011 Business Services, Research and Development MSD, Paul Robinson, Working Life, careers, merck sharp and dohme, recruitment

Paul Robinson, medical director at Merck Sharp & Dohme, looks at how his field is changing, the most enjoyable things …
News

Five capabilities of centered leadership

February 3, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Caroline Webb, Joanna Barsh, Josephine Mogelof, McKinsey & Company, leadership

The business environment has become more demanding: the global financial crisis and subsequent economic downturn have ratcheted up the pressure …
Feature

Pfizer appoints Dr Yvonne Greenstreet to specialty care business

February 3, 2011 Research and Development Dr Yvonne Greenstreet, Pfizer, appointment, specialty care

Dr Yvonne Greenstreet has joined Pfizer to head up medicines development for its Specialty Care business unit. She moves to …
Appointment
Roche Severin Schwann

Roche weathers tough year and looks to pipeline for 2011

February 3, 2011 Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab

Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …
News

Blood clot fears halt cancer trial enrolment

February 3, 2011 Research and Development BMS, Bristol-Myers Squibb, Eli Lilly, NSCLC, lilly, necitumumab, non small cell lung cancer, non-small cell lung cancer

Lilly and BMS have stopped enrolment in a phase III trial of necitumumab, a new treatment for non-small cell lung …
News
Sandwich R&D

Government seeks to salvage Pfizer site

February 2, 2011 Research and Development Pfizer, Sandwich

Science minister David Willetts says the government will do all it can to maintain pharma research in Kent, after Pfizer …
News

Leading universities sound alarm over UK research

February 2, 2011 Research and Development Jobs, Pfizer, Sandwich, universities

Cuts to government funding for research in universities have been condemned by the UK’s top centres of learning. The government …
News
Pfizer's R&D site in Sandwich, Kent

Pfizer to close UK R&D site

February 1, 2011 Research and Development Kent, Pfizer, R&D, Sandwich, closure

Pfizer has announced that it is to close its UK research site at Sandwich in Kent, with the loss of …
News

UK hails high uptake of cervical cancer vaccine

January 31, 2011 Research and Development Cervarix, HPV

The NHS campaign to vaccinate girls against the future risk of developing cervical cancer has been a success, according to …
News

GSK and Actelion drop insomnia treatment

January 30, 2011 Research and Development Actelion, GSK, insomnia

Actelion and GlaxoSmithKline are to abandon development of phase III insomnia drug almorexant because of problems with side-effects.Almorexant a dual …
News

EMA road map to prioritise pharmacovigilance

January 28, 2011 Research and Development, Sales and Marketing EMA, European Medicines Agency, pharmacovigilance

The European Medicines Agency is to prioritise issues such as pharmacovigilance over the next five years, while also looking closely …
News

Bertil Lindmark joins Almirall as R&D head

January 27, 2011 Research and Development Almirall, Bertil Lindmark, appointment, research and development

Almirall has appointed Bertil Lindmark as executive director of R&D following the retirement of Dr Per-Olof Andersson. Bertil joins the …
Appointment

Lilly Oncology chief resigns

January 27, 2011 Research and Development, Sales and Marketing Eli Lilly, John Johnson, Lilly Oncology, appointment, lilly, research and development, sales and marketing

Lilly has an unexpected search on its hands for someone to lead its oncology business after John Johnson unexpectedly announced …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025